Diana Ritchie

2.6k total citations
25 papers, 1.1k citations indexed

About

Diana Ritchie is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Diana Ritchie has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Cancer Research. Recurrent topics in Diana Ritchie's work include Breast Cancer Treatment Studies (7 papers), Bone health and treatments (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Diana Ritchie is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Bone health and treatments (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Diana Ritchie collaborates with scholars based in United Kingdom, Spain and Australia. Diana Ritchie's co-authors include Anna Campbell, Nanette Mutrie, Nora Kearney, Carol Emslie, Fiona Whyte, Alex McConnachie, Andrew Walker, Laura Lee, David Cameron and David Dodwell and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Diana Ritchie

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana Ritchie United Kingdom 11 1.0k 270 268 252 115 25 1.1k
Tracey L. O’Connor United States 17 944 0.9× 332 1.2× 121 0.5× 188 0.7× 74 0.6× 59 1.4k
Steven A. Kuross United States 15 786 0.8× 368 1.4× 177 0.7× 86 0.3× 102 0.9× 19 1.4k
Victoria Chia United States 14 546 0.5× 245 0.9× 115 0.4× 68 0.3× 26 0.2× 39 907
Luísa Pinto Portugal 7 352 0.3× 152 0.6× 129 0.5× 52 0.2× 42 0.4× 26 704
Tracey DiSipio Australia 13 1.8k 1.8× 155 0.6× 98 0.4× 203 0.8× 58 0.5× 25 2.1k
Lucinda Pfalzer United States 18 930 0.9× 177 0.7× 38 0.1× 103 0.4× 73 0.6× 39 1.3k
Neil Chua Canada 21 1.1k 1.0× 270 1.0× 127 0.5× 365 1.4× 8 0.1× 62 1.7k
Sheree Rye Australia 10 1.7k 1.7× 121 0.4× 110 0.4× 168 0.7× 51 0.4× 18 2.0k
Çetın Ordu Türkiye 16 395 0.4× 155 0.6× 112 0.4× 26 0.1× 44 0.4× 61 708
Antônio Carlos Lima Pompeo Brazil 19 203 0.2× 584 2.2× 75 0.3× 99 0.4× 31 0.3× 71 1.2k

Countries citing papers authored by Diana Ritchie

Since Specialization
Citations

This map shows the geographic impact of Diana Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Ritchie more than expected).

Fields of papers citing papers by Diana Ritchie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Ritchie. The network helps show where Diana Ritchie may publish in the future.

Co-authorship network of co-authors of Diana Ritchie

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Ritchie. A scholar is included among the top collaborators of Diana Ritchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Ritchie. Diana Ritchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chadha, Vikas, Paul Cauchi, W. Kincaid, et al.. (2022). Consensus statement for metastatic surveillance of uveal melanoma in Scotland. Eye. 37(5). 894–899. 3 indexed citations
2.
McLernon, David J., et al.. (2021). Outcomes following Notched Ruthenium-106 Plaque Brachytherapy for Juxtapapillary Choroidal Melanomas. Ocular Oncology and Pathology. 7(6). 411–417. 4 indexed citations
3.
Fernando, Indrajit, S. Bowden, Cassandra Brookes, et al.. (2019). Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. Radiotherapy and Oncology. 142. 52–61. 10 indexed citations
4.
Russell, Heather, David Lockington, Diana Ritchie, et al.. (2017). Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience. British Journal of Ophthalmology. 102(1). 74–78. 10 indexed citations
5.
Bayani, Jane, James P. Morden, Peter Bliss, et al.. (2015). Abstract P4-11-03: Androgen receptor expression is an independent marker of lower residual risk in the TACT2 trial (CRUK/05/019). Cancer Research. 75(9_Supplement). P4–11. 1 indexed citations
6.
Coleman, Robert E., David Cameron, David Dodwell, et al.. (2014). Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. The Lancet Oncology. 15(9). 997–1006. 202 indexed citations
7.
Macpherson, Iain R., Caroline A. Bray, C. A. Hopkins, et al.. (2014). Loading Dose Ibandronate Versus Standard Oral Ibandronate in Patients With Bone Metastases From Breast Cancer. Clinical Breast Cancer. 15(2). 117–127. 4 indexed citations
8.
Earl, Helena, Suet‐Feung Chin, Mark Dunning, et al.. (2013). Neo-tAnGo science: A translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy.. Journal of Clinical Oncology. 31(15_suppl). 1015–1015. 1 indexed citations
9.
Mutrie, Nanette, Anna Campbell, Sarah Barry, et al.. (2012). Five-year follow-up of participants in a randomised controlled trial showing benefits from exercise for breast cancer survivors during adjuvant treatment. Are there lasting effects?. Journal of Cancer Survivorship. 6(4). 420–430. 67 indexed citations
10.
Martín, Miguel, Richard H. Bell, Hugues Bourgeois, et al.. (2012). Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid. Clinical Cancer Research. 18(17). 4841–4849. 96 indexed citations
11.
Sandinha, Teresa, et al.. (2011). Low Dose Orbital Radiotherapy for Thyroid Eye Disease. Orbit. 30(6). 269–274. 9 indexed citations
12.
Coleman, Robert E., Matthew Winter, David Cameron, et al.. (2010). The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer. 102(7). 1099–1105. 168 indexed citations
13.
Stopeck, Alison, Miguel Martín, Diana Ritchie, et al.. (2010). Abstract P6-14-01: Effect of Denosumab Versus Zoledronic Acid Treatment in Patients with Breast Cancer and Bone Metastases: Results from the Extended Blinded Treatment Phase. Cancer Research. 70(24_Supplement). P6–14. 12 indexed citations
14.
Tahir, Mohammad, et al.. (2008). Radiation-Induced Angiosarcoma Following Conservative Surgery for Lobular Breast Cancer. The Breast Journal. 14(4). 390–391. 1 indexed citations
16.
Mutrie, Nanette, Anna Campbell, Fiona Whyte, et al.. (2007). Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ. 334(7592). 517–517. 316 indexed citations
17.
Emslie, Carol, Fiona Whyte, Anna Campbell, et al.. (2006). 'I wouldn't have been interested in just sitting round a table talking about cancer'; exploring the experiences of women with breast cancer in a group exercise trial. Health Education Research. 22(6). 827–838. 107 indexed citations
18.
Tahir, M., et al.. (2006). Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery. PubMed. 3(1). 26–26. 25 indexed citations
19.
Mano, Max S., et al.. (2005). Locally advanced breast cancer in octogenarian women. Breast Cancer Research and Treatment. 89(1). 81–90. 6 indexed citations
20.
Kitching, A. Richard, et al.. (2001). Chloramine-induced hemolysis associated with neurological symptoms in a home hemodialysis patient.. PubMed. 55(3). 259–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026